Pelong, Diosdado B.
HRN: 07-15-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/27/2023
04/06/2023
IV
2.25 Grams
Q6H
CAP-MR
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose